Literature DB >> 30144228

Long-term treatment gains of a brief exposure-based treatment for PTSD.

Johanna Thompson-Hollands1,2, Brian P Marx1,2, Daniel J Lee2, Patricia A Resick3, Denise M Sloan1,2.   

Abstract

BACKGROUND: Written exposure therapy (WET) is a 5-session PTSD treatment that may address barriers in treatment for posttraumatic stress disorder (PTSD) given its brevity and tolerability. A recent study found outcomes for WET were non-inferior to outcomes from Cognitive Processing Therapy (CPT) through 36 weeks from first treatment session (Sloan, Marx, Lee, & Resick, 2018); the current study examined whether treatment gains were maintained through 60 weeks from first session, and also evaluated both treatments' effect on depressive symptoms.
METHODS: The study enrolled 126 individuals with PTSD randomized to WET or CPT. Assessments were conducted at baseline and 6, 12, 24, 36, and 60 weeks following the first treatment session. PTSD diagnosis and symptom severity were determined via the Clinician Administered PTSD Scale for DSM-5 (CAPS-5), and depression symptoms were assessed using the Beck Depression Inventory-2.
RESULTS: WET remained non-inferior to CPT through the 60 week assessment; the groups had a difference of less than 3 points in their total CAPS-5 scores, and within-condition effects on PTSD were large (WET d = 1.23; CPT d = 1.38). Both treatments significantly reduced depressive symptoms over the 60 week study, with the CPT group experiencing a more rapid decrease. The between-condition effect of treatment on depression was small (d = .19).
CONCLUSIONS: WET is a treatment that is non-inferior to CPT with regard to PTSD symptoms, with treatment effects that are long-lasting. Additionally, both WET and CPT demonstrated substantial effects on depressive symptoms. WET should be considered a good option for PTSD treatment. Published 2018. This article is a U.S. Government work and is in the public domain in the USA.

Entities:  

Keywords:  PTSD; clinical trials; therapy; trauma

Mesh:

Year:  2018        PMID: 30144228      PMCID: PMC6168424          DOI: 10.1002/da.22825

Source DB:  PubMed          Journal:  Depress Anxiety        ISSN: 1091-4269            Impact factor:   6.505


  15 in total

Review 1.  A critical evaluation of the complex PTSD literature: implications for DSM-5.

Authors:  Patricia A Resick; Michelle J Bovin; Amber L Calloway; Alexandra M Dick; Matthew W King; Karen S Mitchell; Michael K Suvak; Stephanie Y Wells; Shannon Wiltsey Stirman; Erika J Wolf
Journal:  J Trauma Stress       Date:  2012-06

2.  Clinical significance: a statistical approach to defining meaningful change in psychotherapy research.

Authors:  N S Jacobson; P Truax
Journal:  J Consult Clin Psychol       Date:  1991-02

3.  Post-traumatic stress disorder: findings from the Australian National Survey of Mental Health and Well-being.

Authors:  M Creamer; P Burgess; A C McFarlane
Journal:  Psychol Med       Date:  2001-10       Impact factor: 7.723

4.  A meta-analytic review of prolonged exposure for posttraumatic stress disorder.

Authors:  Mark B Powers; Jacqueline M Halpern; Michael P Ferenschak; Seth J Gillihan; Edna B Foa
Journal:  Clin Psychol Rev       Date:  2010-05-02

5.  The Clinician-Administered PTSD Scale for DSM-5 (CAPS-5): Development and initial psychometric evaluation in military veterans.

Authors:  Frank W Weathers; Michelle J Bovin; Daniel J Lee; Denise M Sloan; Paula P Schnurr; Danny G Kaloupek; Terence M Keane; Brian P Marx
Journal:  Psychol Assess       Date:  2017-05-11

6.  Randomized trial of prolonged exposure for posttraumatic stress disorder with and without cognitive restructuring: outcome at academic and community clinics.

Authors:  Edna B Foa; Elizabeth A Hembree; Shawn P Cahill; Sheila A M Rauch; David S Riggs; Norah C Feeny; Elna Yadin
Journal:  J Consult Clin Psychol       Date:  2005-10

7.  Utilization of evidence-based psychotherapies in Veterans Affairs posttraumatic stress disorder outpatient clinics.

Authors:  Erin P Finley; Hector A Garcia; Norma S Ketchum; Donald D McGeary; Cindy A McGeary; Shannon Wiltsey Stirman; Alan L Peterson
Journal:  Psychol Serv       Date:  2014-11-24

8.  Meta-analysis of dropout in treatments for posttraumatic stress disorder.

Authors:  Zac E Imel; Kevin Laska; Matthew Jakupcak; Tracy L Simpson
Journal:  J Consult Clin Psychol       Date:  2013-01-21

9.  Posttraumatic stress disorder and depression following trauma: understanding comorbidity.

Authors:  Meaghan L O'Donnell; Mark Creamer; Phillipa Pattison
Journal:  Am J Psychiatry       Date:  2004-08       Impact factor: 18.112

10.  Written exposure as an intervention for PTSD: a randomized clinical trial with motor vehicle accident survivors.

Authors:  Denise M Sloan; Brian P Marx; Michelle J Bovin; Brian A Feinstein; Matthew W Gallagher
Journal:  Behav Res Ther       Date:  2012-07-20
View more
  9 in total

1.  Perceived Barriers and Preliminary PTSD Outcomes in an Open Pilot Trial of Written Exposure Therapy With Latinx Immigrants.

Authors:  Arthur R Andrews; Laura M Acosta; M Natalia Acosta Canchila; James K Haws; Kathryn J Holland; Natalie R Holt; Allura L Ralston
Journal:  Cogn Behav Pract       Date:  2021-06-20

2.  Predictors of Dropout in Cognitive Processing Therapy for PTSD: An Examination of Trauma Narrative Content.

Authors:  Elizabeth Alpert; Adele M Hayes; J Ben Barnes; Denise M Sloan
Journal:  Behav Ther       Date:  2019-11-26

3.  Brief novel therapies for PTSD: Written Exposure Therapy.

Authors:  Johanna Thompson-Hollands; Brian P Marx; Denise M Sloan
Journal:  Curr Treat Options Psychiatry       Date:  2019-06-05

4.  The temporal sequence of change in PTSD symptoms and hypothesized mediators in Cognitive Processing Therapy and Written Exposure Therapy for PTSD.

Authors:  Daniel J Lee; Brian P Marx; Johanna Thompson-Hollands; Matthew W Gallagher; Patricia A Resick; Denise M Sloan
Journal:  Behav Res Ther       Date:  2021-06-24

5.  Longitudinal change in self-reported peritraumatic dissociation during and after a course of posttraumatic stress disorder treatment: Contributions of symptom severity and time.

Authors:  Johanna Thompson-Hollands; Brian P Marx; Daniel J Lee; Denise M Sloan
Journal:  Psychol Trauma       Date:  2020-09-03

6.  The efficacy and acceptability of exposure therapy for the treatment of post-traumatic stress disorder in children and adolescents: a systematic review and meta-analysis.

Authors:  Tengyue Huang; Haomiao Li; Yajie Xiang; Xinyu Zhou; Shiyu Tan; Siyu Xie; Qisheng Cheng
Journal:  BMC Psychiatry       Date:  2022-04-12       Impact factor: 3.630

7.  Study design comparing written exposure therapy to cognitive processing therapy for PTSD among military service members: A noninferiority trial.

Authors:  Denise M Sloan; Brian P Marx; Patricia A Resick; Stacey Young-McCaughan; Katherine A Dondanville; Jim Mintz; Brett T Litz; Alan L Peterson
Journal:  Contemp Clin Trials Commun       Date:  2019-12-10

8.  Comparing written exposure therapy to Prolonged Exposure for the treatment of PTSD in a veteran sample: A non-inferiority randomized design.

Authors:  Denise M Sloan; Brian P Marx; Ronald Acierno; Michael Messina; Travis A Cole
Journal:  Contemp Clin Trials Commun       Date:  2021-04-07

9.  Long-term outcomes of psychological treatment for posttraumatic stress disorder: a systematic review and meta-analysis.

Authors:  Maxi Weber; Sarah Schumacher; Wiebke Hannig; Jürgen Barth; Annett Lotzin; Ingo Schäfer; Thomas Ehring; Birgit Kleim
Journal:  Psychol Med       Date:  2021-06-28       Impact factor: 7.723

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.